CULLINAN ASSOCIATES INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CULLINAN ASSOCIATES INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$769,896
-17.2%
20,4000.0%0.04%
-11.8%
Q2 2023$929,424
+12.3%
20,4000.0%0.05%
+6.2%
Q1 2023$827,424
+79460.0%
20,4000.0%0.05%
-17.2%
Q4 2022$1,040
-99.9%
20,400
+14.0%
0.06%
-4.9%
Q3 2022$964,000
-16.8%
17,900
-0.7%
0.06%
-14.1%
Q2 2022$1,158,000
-17.2%
18,0250.0%0.07%
-2.7%
Q1 2022$1,398,000
-9.9%
18,025
-0.3%
0.07%
-7.6%
Q4 2021$1,552,000
+6.7%
18,0750.0%0.08%
-1.2%
Q3 2021$1,454,000
-0.1%
18,0750.0%0.08%
-1.2%
Q2 2021$1,455,000
+4.1%
18,075
+9.0%
0.08%
+1.2%
Q1 2021$1,398,000
+17.5%
16,575
+11.8%
0.08%
+12.7%
Q4 2020$1,190,000
+15.0%
14,825
-41.2%
0.07%
-19.3%
Q1 2016$1,035,000
+1.3%
25,195
-6.0%
0.09%
-1.1%
Q4 2015$1,022,000
-71.7%
26,795
-75.6%
0.09%
-73.0%
Q3 2015$3,613,000
-54.5%
109,995
-3.1%
0.33%
-49.5%
Q2 2015$7,934,000
-8.5%
113,459
-10.4%
0.65%
-2.8%
Q1 2015$8,672,000
+19.1%
126,604
+24.7%
0.67%
-18.9%
Q3 2014$7,284,000
+13.4%
101,495
+16.2%
0.83%
+13.5%
Q1 2014$6,425,000
+10.3%
87,321
+4.3%
0.73%
+8.3%
Q4 2013$5,825,000
+4.5%
83,757
+4.1%
0.68%
-10.4%
Q2 2013$5,572,00080,4420.75%
Other shareholders
BAXTER INTL INC shareholders Q4 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders